ATE76904T1 - Monoklonaler antikoerper in bezug auf heilmittelresistente krebse und dessen herstellung. - Google Patents

Monoklonaler antikoerper in bezug auf heilmittelresistente krebse und dessen herstellung.

Info

Publication number
ATE76904T1
ATE76904T1 AT86112391T AT86112391T ATE76904T1 AT E76904 T1 ATE76904 T1 AT E76904T1 AT 86112391 T AT86112391 T AT 86112391T AT 86112391 T AT86112391 T AT 86112391T AT E76904 T1 ATE76904 T1 AT E76904T1
Authority
AT
Austria
Prior art keywords
hybridoma
mouse
cells
medium
cell
Prior art date
Application number
AT86112391T
Other languages
English (en)
Inventor
Takashi Tsuruo
Hirofumi Hamada
Haruo Sugano
Original Assignee
Japan Found Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Found Cancer filed Critical Japan Found Cancer
Application granted granted Critical
Publication of ATE76904T1 publication Critical patent/ATE76904T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/861—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgG3, IgG4, IgA, or IgY
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864—Monoclonal

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT86112391T 1985-09-11 1986-09-08 Monoklonaler antikoerper in bezug auf heilmittelresistente krebse und dessen herstellung. ATE76904T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP60201445A JPS6261596A (ja) 1985-09-11 1985-09-11 薬剤耐性癌に関するモノクロ−ナル抗体およびその製造
EP86112391A EP0214640B1 (de) 1985-09-11 1986-09-08 Monoklonaler Antikörper in Bezug auf heilmittelresistente Krebse und dessen Herstellung

Publications (1)

Publication Number Publication Date
ATE76904T1 true ATE76904T1 (de) 1992-06-15

Family

ID=16441205

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86112391T ATE76904T1 (de) 1985-09-11 1986-09-08 Monoklonaler antikoerper in bezug auf heilmittelresistente krebse und dessen herstellung.

Country Status (5)

Country Link
US (1) US5087560A (de)
EP (1) EP0214640B1 (de)
JP (1) JPS6261596A (de)
AT (1) ATE76904T1 (de)
DE (1) DE3685533T2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2564412B2 (ja) * 1990-03-02 1996-12-18 財団法人癌研究会 薬剤耐性癌に対するキメラ抗体およびその製造
DE69128253T2 (de) * 1990-10-29 1998-06-18 Chiron Corp Bispezifische antikörper, verfahren zu ihrer herstellung und deren verwendungen
US20080124329A1 (en) * 2006-07-05 2008-05-29 Schreiner George F Conditioned Cell Immunization
FR2906533B1 (fr) * 2006-09-28 2013-02-22 Pf Medicament Procede de generation d'anticorps actifs contre un antigene de resistance,anticorps obtenus par ledit procede et leurs utilisations

Also Published As

Publication number Publication date
EP0214640A3 (en) 1988-11-30
JPS6261596A (ja) 1987-03-18
DE3685533D1 (de) 1992-07-09
US5087560A (en) 1992-02-11
EP0214640A2 (de) 1987-03-18
DE3685533T2 (de) 1993-02-18
JPH0430278B2 (de) 1992-05-21
EP0214640B1 (de) 1992-06-03

Similar Documents

Publication Publication Date Title
AU1198288A (en) Monoclonal antibodies against melanoma-associated antigens, hybrid cell lines producing these antibodies, and use therefor
ES8105151A1 (es) Un metodo para la preparacion de un anticuerpo monoclonico.
ATE58554T1 (de) Menschlicher hybridomfusionspartner zur herstellung menschlicher monoklonaler antikoerper.
DE3070848D1 (en) Monoclonal antibody to human t cells, method for preparing it, hybrid cell line producing it, therapeutic composition comprising it and diagnostic method using it
AU6501280A (en) Hybrid cell line for producing monoclonal antibody
ES8303095A1 (es) Un metodo de preparacion de un inticuerpo monocloral.
AU6496180A (en) Hybridoma for producing monoclonal antibodies
AU545222B2 (en) Hybridoma for producing monoconal antibodies
SE8106528L (sv) Framstellning av menskliga monoklonala antikroppar medelst menskliga hybridom
EP0102601A3 (de) Monoklonaler Antikörper, Verfahren zu seiner Herstellung und Verwendung dieses monoklonalen Antikörpers
ATE76904T1 (de) Monoklonaler antikoerper in bezug auf heilmittelresistente krebse und dessen herstellung.
JPS6468398A (en) Monoclonal anti-idiotype antibody and hybridoma and use thereof
EP0131878A3 (de) Verfahren zur Herstellung menschlicher monoklonaler Antikörper
EP0184369A3 (en) Monoclonal antibody specific for a mammary tumor cell surface antigen
EP0200554A3 (de) Spezifische monoklonale Antikörper für Interleukin-2 der Maus produzierende Hybridome
EP0119859A3 (de) Monoklonale Antikörper, Verfahren zu ihrer Herstellung und Methoden für ihre Verwendung
JPS6443199A (en) Monoclonal antibody 4c1 to human cancerous cell and hybridoma capable of producing said antibody
JPS6423897A (en) Monoclonal antibody
JPS6486882A (en) Monoclonal antibody
JPS6471496A (en) Monoclonal antibody nky13
KR890004729A (ko) 항 이디오타잎 항체를 이용하는 종양 면역 치료법

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee